Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors.
Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors. Research Abstract Details
Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors. Publishing Authors By Initials
Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors. Journal Published:
PUBLICATION TYPE: Journal Article
Journal: Cancer chemotherapy reports. Part 1
VOLUME: 56
Page Numbers: 53-9
Journal Abbreviation:
ISSN: 0069-0112
DAY: 20
MONTH: Feb
YEAR: 1972
Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 7607105
Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors. Keywords Mesh Terms:
KEYWORDS: Urea
MESH TERMS: therapeutic use
Chemical & Substance for Abstract: Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors. Information
Substance Name: Urea
Registry Number: 57-13-6
Grant and Affiliation Information for Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors.
AFFILIATION:
Country: UNITED STATES
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Cancer Chemother Rep
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Combined therapy with cytosine arabinoside NSC-63878 and 1,3-bis2-chloroethyl-1-nitrosourea BCNU; NSC-409962 for advanced solid tumors Related Publications